Z2001

Zonisamide sodium salt

≥98% (HPLC), NO scavenger, powder

• Sinónimos: 1,2-Benzisoxazole-3-methanesulfonamide sodium-potassium salt, Aleviatin sodium-potassium salt, Exceglan sodium-potassium salt, Excegram sodium-potassium salt
• Fórmula empírica (notación de Hill): C₈H₇N₂NaO₃S
• Número CAS: 68291-98-5
• Peso molecular: 234.21
• UNSPSC Code: 12352200
• PubChem Substance ID: 24278783
• NACRES: NA.77
• MDL number: MFCD01744844
• Assay: ≥98% (HPLC)
• Form: powder
• Quality level: 100

Propiedades

• Nombre del producto: Zonisamide sodium salt, ≥98% (HPLC), powder
• Quality Level: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: H₂O: >5 mg/mL
• originator: Eisai
• SMILES string: [Na]NS(=O)(=O)Cc1noc2ccccc12
• InChI: 1S/C8H7N2O3S.Na/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7;/h1-4H,5H2,(H-,9,11,12);/q-1;+1
• InChI key: ZVBIRPKGWOVBLG-UHFFFAOYSA-N
• Gene Information: human ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335)

Descripción

Biochem/physiol Actions

Zonisamide sodium salt is an anti-epileptic and also scavenges nitric oxide (NO).

Zonisamide sodium salt is an anti-epileptic. It is effective in various animal epilepsy models and humans with both partial and generalized epileptic seizures. Zonisamide sodium salt also scavenges nitric oxide (NO).

Features and Benefits

This compound was developed by Eisai. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Información de seguridad

• pictograms: GHS07
• signalword: Warning
• hcodes: H302
• pcodes: P264 - P270 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral
• Clase de almacenamiento: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: dust mask type N95 (US), Eyeshields, Gloves